Etrax

Etrax40 mg

Tablet

Levamisole

ACI Limited

Product Code : 6259
MRP 1.00
10% Off
Best PriceTk
/
1
Section

Medicine overview

Indications of Etrax 40 mg

Etrax 40 mg is a fast acting drug which acts on nematode nerve ganglia paralysing the worm’s musculature within seconds of contact. Unable to maintain their position, the worms are then ejected by normal peristaltic movement, usually within 24 hours of Etrax 40 mg administration. Although it is ... Read moreEtrax 40 mg is a fast acting drug which acts on nematode nerve ganglia paralysing the worm’s musculature within seconds of contact. Unable to maintain their position, the worms are then ejected by normal peristaltic movement, usually within 24 hours of Etrax 40 mg administration. Although it is certain that Etrax 40 mg primarily influences the neuromuscular system of nematodes, it is possible that in some helminthes the inhibition of the fumarate reductase system contributes to the anthelmintic efficacy of Etrax 40 mg. Etrax 40 mg is indicated for the treatment of infections by the following gastrointestinal wormspecies: Ascaris lumbricoides: Roundworm Necator americanus: Hookworm Ancylostoma duodenal: Hookworm E nterobius vermicularis: Pinworm Trichuris trichuria: Whipworm Strongyloides stercoralis: Threadworm Trichostrongylus colubriformis

Theropeutic Class

Anthelmintic

Pharmacology

Etrax 40 mg is the active laevo-isomer of tetramisole. It works by paralysing susceptible intestinal worms which are then excreted from the intestines. Etrax 40 mg also enhances cellular immune responses in humans.

Dosage & Administration of Etrax 40 mg

The following doses of Etrax 40 mg are given as a single administration, preferably after a light meal. Age 1-4 year: 1 Tablets or 5 ml Syrup Age 5-15 year: 2 Tablets or 10 ml Syrup Age 16 year and over: 3 Tablets or 15 ml Syrup In cases of severe hookworm infection it is suggested that a second standard dose be given one or seven days after the first, whichever timing is feasible.

Dosage of Etrax 40 mg

The following doses of Etrax 40 mg are given as a single administration, preferably after a light meal. Age 1-4 year: 1 Tablets or 5 ml Syrup Age 5-15 year: 2 Tablets or 10 ml Syrup Age 16 year and over: 3 Tablets or 15 ml Syrup In cases of severe hookworm infection it is suggested that a second standard dose be given one or seven days after the first, whichever timing is feasible.

Interaction of Etrax 40 mg

May increase toxicity of phenytoin. Increases bioavailability of ivermectin; decreases bioavailability of albendazole. Alcohol causes disulfiram-like reaction.

Contraindications

There is no absolute contra-indication to the use of Etrax 40 mg

Side Effects of Etrax 40 mg

Side-effects are infrequent. They are usually mild and transient and include nausea, vomiting, abdominal pain, giddiness(dizziness) and headache. An encephalopathylike syndrome has been reported to have occurred in a few patients two or three weeks after treatment.

Pregnancy & Lactation

Although studies in animals have shown that Etrax 40 mg produces no teratogenic effects, current medical practice requires that the benefits of any drug used during pregnancy should be weighed against the possible dangers.

Precautions & Warnings

Effect on ability to drive or operate machinery: There is no evidence to suggest that Etrax 40 mg , used for anthelmintic purpose, will produce sedation. Mild and transient giddiness is an infrequent side-effect of treatment. No precautions are suggested concerning the ability to drive or operate machinery.In case of concurrent microfilaraemia transient fever may occur.

Overdose Effects of Etrax 40 mg

Counter possible anticholinesterase activity with e.g. atropine. Control blood pressure and respiration . Do not use sedatives.

Storage Conditions

Tablet: Store in room temperature and protect from moisture.Syrup: Store in room temperature and protect from light.

Drug Classes

Anthelmintic

Mode Of Action

Etrax 40 mg is the active laevo-isomer of tetramisole. It works by paralysing susceptible intestinal worms which are then excreted from the intestines. Etrax 40 mg also enhances cellular immune responses in humans.

Pregnancy

Although studies in animals have shown that Etrax 40 mg produces no teratogenic effects, current medical practice requires that the benefits of any drug used during pregnancy should be weighed against the possible dangers.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.